The Top 15 R&D Budgets
In the world of drug development, you're only as good as your pipeline. As many companies' older blockbuster drugs go off-patent, analysts are looking at pipelines to see who'll have what it takes to survive and grow, and which companies will fall behind in the race to develop new drugs.
A recent EU report ranked the world's largest R&D budgets, and Pfizer took the lead--not just among drug developers but among all industries--with a staggering $8.34 billion budget in 2006. But as this report shows, spending more money doesn't necessarily make for a better pipeline. Take a look at this list of the top 15 pharmaceutical R&D budgets to find out how they're spending all those billions of dollars, who's keeping their edge, and who's falling behind.
1. Pfizer
5. Roche
6. Novartis
7. Merck
8. AstraZeneca
9. Amgen
10. Bayer
11. Eli Lilly
12. Wyeth
14. Abbott
15. Schering-Plough
Read more: http://www.fiercebiotech.com/special-reports/top-15-r-d-budgets?sourceform=FBRwm#ixzz0TvzabT0O














0 comments:
Post a Comment
Thank you for your comment. All comments are moderated and must be approved before showing up.